期刊文献+

MMP12、MMP13基因启动子区多态性与子宫内膜异位症遗传易感性研究 被引量:2

The functional polymorphisms on promoter region of matrix metalloproteinase-12,-13 genes with genetic susceptibility to endometriosis
下载PDF
导出
摘要 目的探讨MMP12、MMP13启动子区基因多态性与安徽地区育龄妇女的子宫内膜异位症(EMs)遗传易感性的关系。方法采用聚合酶链反应-限制性片段长度多态方法(PCR-RFLP)对221例EMs及235例对照组MMP12 A-82G、MMP-13 A-77G基因多态位点的基因型分析。结果 MMP12、MMP13各个基因型及等位基因频率在对照组和病例组的分布比较差异无统计学意义。结论 MMP12、MMP13启动子区A-82G、A-77G多态性与EMs无明显相关性,MMP12、MMP13启动子区的多态位点可能和安徽地区育龄妇女EMs的易感性无关。 Objective To identify the genetic susceptibility of the function polymorphisms on region of matrix metalloproteinase(MMP)-12,-13 gene responsible to endometriosis(EMs) in Anhui region of women.Methods The study cohort included 221 patients diagnosed with EMs.Control group consisted of 235 healthy women without EMs.Genotyping of the MMP-12、MMP-13 gene polymorphisms 82A/G and 77A/G were performed by polymerase chain reaction(PCR) and restriction fragment length polymorphism(RFLP) analysis.Results The genotype and allele frequencies of two loci were no significant difference between cases and controls.Conclusion The study results suggest that the functional polymorphism on promoter region MMP-12,MMP-13 gene may be not associated with the risk of EMs in the Anhui region of women.
出处 《安徽医科大学学报》 CAS 北大核心 2012年第3期314-316,共3页 Acta Universitatis Medicinalis Anhui
关键词 子宫内膜异位症 MMP12 MMP13 基因多态性 endometriosis MMP-12 MMP-13 single nucleotide polymorphism
  • 相关文献

参考文献3

二级参考文献34

  • 1郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:280
  • 2XiaJin,GangKuang,Li-ZhenWei,YanLi,RuiWang,WeiGuo,NaWang,Shu-MeiFang,Zhi-FengChen,Jian-HuiZhang.No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China[J].World Journal of Gastroenterology,2005,11(16):2385-2389. 被引量:7
  • 3沈蓉,田永杰.MMP-9、TIMP-1在子宫内膜异位症患者子宫内膜中的表达及意义[J].山东医药,2006,46(17):20-22. 被引量:6
  • 4Kim YI, Park S, Jeoung DI, et al. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells. Biochem Biophys Res Commun, 2003, 307(2): 281-289.
  • 5Bruner KL, Matrisian LM, Rodgers WH, et al. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest, 1997, 99( 12): 2851-2857.
  • 6Bullimore DW. Endometriosis is sustained by tumour necrosis factor-alpha. Med Hypotheses, 2003, 60( 1 ): 84-88.
  • 7Cox KE, Piva M, Sharpe-Timms KL. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod, 2001, 65(4): 1297-1303.
  • 8Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci, 2002, 3(4): 409-421.
  • 9Henriet P, Cornet PB, Lemoine P, et al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs). Ann N Y Acad Sci, 2002, 955(1): 119-138.
  • 10Chen SL, Wu YS, Shieh HY, et al. P53 is a regulator of the metastasis suppressor gene Nm23-H1. Mol Carcinog, 2003, 36 (4): 204-214.

共引文献24

同被引文献44

  • 1Leyland N,Casper R,Laberge P,et al.Endometriosis:di-agnosis and management [ J].J Obstet Gynaecol Can,2010,32(7 S2):1-32.
  • 2Yang Z,Li C,Wang X,et al.Dauricine induces apoptosis,inhibits proliferation and invasion through inhibiting NF-kap-paB signaling pathway in colon cancer cells [ J].J Cell Physi-ol,2010,225(1):266-275.
  • 3Cooke G,Armstrong ME,Donnelly SC.Macrophage migration inhibitory factor(MIF),enzymatic activity and the inflamma-tory response [J].Biofactors,2009,35(2):165-168.
  • 4American Fertility Society.Revised American Fertility Society classification of endometriosis:1985 [J].Fertil Steril,1985,43(3):351-352.
  • 5Goumenou A,Matalliotakis I,Mahutte N,et al.Endometri-osis mimicking advanced ovarian cancer [ J ].Fertil Steril,2006,86(1):219-225.
  • 6Olovsson M.Immunological aspects of endometriosis:an up-date [J].Am J Reprod Immunol,2011,66(S11):101-104.
  • 7Kagoshima M,Ifo K,Cosio B,et al.Glucocorticoid sup-pression of nuclear factor.Kappa B:a role for histone modifi-cations [J].Biochem Soc Trans,2003,31(1):60-65.
  • 8Papa S,Bubici C,Zazzeroni F,et al.The NF-kappa B-mediated control of the JNK cascade in the antagonism of pro-grammed cell death in health and disease [ J ].Cell Death Differ,2006,13(5):712-729.
  • 9Chapman NR,Europe-Finner GN,RobsonSC.Expression and deoxyribonucleic acid binding activity of the nuclear fac-tor kappa B family in the human myometrium during pregnan-cy and labor [J].Clin J Endocrinol Metab,2004,89(11):5683-5693.
  • 10Lappas M,Rice GE.The role and regulation of the nuclear factor kappa B signalling pathway in human labour [ J].Pla-centa,2007,28(56):543-556.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部